Leveljump Healthcare Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Leveljump Healthcare has been growing earnings at an average annual rate of 22.2%, while the Healthcare industry saw earnings growing at 15% annually. Revenues have been growing at an average rate of 30.6% per year.
Belangrijke informatie
22.2%
Groei van de winst
136.7%
Groei van de winst per aandeel
Healthcare Groei van de industrie | -6.7% |
Inkomstengroei | 30.6% |
Rendement op eigen vermogen | -45.1% |
Nettomarge | -13.8% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Leveljump Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 15 | -2 | 3 | 0 |
31 Mar 24 | 14 | -2 | 3 | 0 |
31 Dec 23 | 13 | -2 | 3 | 0 |
30 Sep 23 | 11 | -1 | 2 | 0 |
30 Jun 23 | 11 | 0 | 2 | 0 |
31 Mar 23 | 10 | 0 | 2 | 0 |
31 Dec 22 | 9 | 0 | 2 | 0 |
30 Sep 22 | 8 | -1 | 3 | 0 |
30 Jun 22 | 8 | -1 | 3 | 0 |
31 Mar 22 | 7 | -2 | 3 | 0 |
31 Dec 21 | 7 | -2 | 4 | 0 |
30 Sep 21 | 6 | -13 | 3 | 0 |
30 Jun 21 | 6 | -13 | 3 | 0 |
31 Mar 21 | 6 | -12 | 2 | 0 |
31 Dec 20 | 5 | -12 | 1 | 0 |
30 Sep 20 | 5 | 0 | 1 | 0 |
30 Jun 20 | 5 | 0 | 1 | 0 |
31 Mar 20 | 5 | 0 | 1 | 0 |
31 Dec 19 | 5 | 0 | 1 | 0 |
31 Dec 18 | 4 | 0 | 1 | 0 |
Kwaliteitswinsten: JUMP is currently unprofitable.
Groeiende winstmarge: JUMP is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: JUMP is unprofitable, but has reduced losses over the past 5 years at a rate of 22.2% per year.
Versnelling van de groei: Unable to compare JUMP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: JUMP is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8%).
Rendement op eigen vermogen
Hoge ROE: JUMP has a negative Return on Equity (-45.08%), as it is currently unprofitable.